BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8184041)

  • 1. Screening mammography in women aged 40-49 years: analysis of cost-effectiveness.
    Rosenquist CJ; Lindfors KK
    Radiology; 1994 Jun; 191(3):647-50. PubMed ID: 8184041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cost-effectiveness of mammographic screening strategies.
    Lindfors KK; Rosenquist CJ
    JAMA; 1995 Sep; 274(11):881-4. PubMed ID: 7674501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computer-aided detection of breast cancer: a cost-effectiveness study.
    Lindfors KK; McGahan MC; Rosenquist CJ; Hurlock GS
    Radiology; 2006 Jun; 239(3):710-7. PubMed ID: 16569787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
    Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
    J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of breast cancer screening in women on dialysis.
    Wong G; Howard K; Chapman JR; Craig JC
    Am J Kidney Dis; 2008 Nov; 52(5):916-29. PubMed ID: 18789566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of a quality-controlled mammography screening program from the Swiss statutory health-care perspective: quantitative assessment of the most influential factors.
    Neeser K; Szucs T; Bulliard JL; Bachmann G; Schramm W
    Value Health; 2007; 10(1):42-53. PubMed ID: 17261115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland.
    de Gelder R; Bulliard JL; de Wolf C; Fracheboud J; Draisma G; Schopper D; de Koning HJ
    Eur J Cancer; 2009 Jan; 45(1):127-38. PubMed ID: 19038540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of annual versus biennial screening mammography for women with high mammographic breast density.
    Pataky R; Ismail Z; Coldman AJ; Elwood M; Gelmon K; Hedden L; Hislop G; Kan L; McCoy B; Olivotto IA; Peacock S
    J Med Screen; 2014 Dec; 21(4):180-8. PubMed ID: 25186116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of digital mammography screening before the age of 50 in The Netherlands.
    Sankatsing VD; Heijnsdijk EA; van Luijt PA; van Ravesteyn NT; Fracheboud J; de Koning HJ
    Int J Cancer; 2015 Oct; 137(8):1990-9. PubMed ID: 25895135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Needle core biopsy guided with mammography: a study of cost-effectiveness.
    Lindfors KK; Rosenquist CJ
    Radiology; 1994 Jan; 190(1):217-22. PubMed ID: 8259408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of the Norwegian breast cancer screening program.
    van Luijt PA; Heijnsdijk EA; de Koning HJ
    Int J Cancer; 2017 Feb; 140(4):833-840. PubMed ID: 27861849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age.
    Salzmann P; Kerlikowske K; Phillips K
    Ann Intern Med; 1997 Dec; 127(11):955-65. PubMed ID: 9412300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Health economics analysis of breast cancer screening].
    Boncz I; Sebestyén A; Gulácsi L; Pál M; Dózsa C
    Magy Onkol; 2003; 47(2):149-54. PubMed ID: 12975661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging.
    Plevritis SK; Kurian AW; Sigal BM; Daniel BL; Ikeda DM; Stockdale FE; Garber AM
    JAMA; 2006 May; 295(20):2374-84. PubMed ID: 16720823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness.
    Kerlikowske K; Salzmann P; Phillips KA; Cauley JA; Cummings SR
    JAMA; 1999 Dec; 282(22):2156-63. PubMed ID: 10591338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening mammography beginning at age 40 years: a reappraisal of cost-effectiveness.
    Rosenquist CJ; Lindfors KK
    Cancer; 1998 Jun; 82(11):2235-40. PubMed ID: 9610704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the Cost-Effectiveness of Updated Breast Cancer Screening Guidelines for Average-Risk Women.
    Tina Shih YC; Dong W; Xu Y; Shen Y
    Value Health; 2019 Feb; 22(2):185-193. PubMed ID: 30711063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A model-based comparison of breast cancer screening strategies: mammograms and clinical breast examinations.
    Shen Y; Parmigiani G
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):529-32. PubMed ID: 15734983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of breast cancer screening policies using simulation.
    Gocgun Y; Banjevic D; Taghipour S; Montgomery N; Harvey BJ; Jardine AK; Miller AB
    Breast; 2015 Aug; 24(4):440-8. PubMed ID: 25866350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-Effectiveness of Tomosynthesis in Annual Screening Mammography.
    Kalra VB; Wu X; Haas BM; Forman HP; Philpotts LE
    AJR Am J Roentgenol; 2016 Nov; 207(5):1152-1155. PubMed ID: 27547861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.